Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
36M
Market Cap:
$0.06B
Avg Volume:
324999
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Novabay (NBY) Receives FDA 510(K) Clearance For Neutrophase Wound Cleanser
Aug 27, 2012 12:58 PM |
Novabay Pharma (NBY) Completes End-Of-Phase 2A FDA Meeting For Dermatology Program
Jun 06, 2012 07:27 AM |
More Articles on NBY..
Press Releases
NovaBay Pharmaceuticals Reports First Quarter Financial Results and Clinical and Business Update
May 02, 2013 08:15 AM |
RedChip Emerging Growth Showcase Takes Place May 1
Apr 23, 2013 11:16 AM |
CRDC
,
INO
"The RedChip Money Report" Now Airing Nationally on WGN
Apr 12, 2013 02:49 PM |
SPEX
More Press Releases on NBY..
SEC Filings
Form 4 NovaBay Pharmaceuticals, For: Mar 05 Filed by: Bley Keith R (10K)
Mar 06, 2013 07:32 PM
Form 3 NovaBay Pharmaceuticals, For: Mar 04 Filed by: Bley Keith R (10K)
Mar 06, 2013 06:52 PM
Form 4 NovaBay Pharmaceuticals, For: Jan 30 Filed by: Wicks Tony D.S. (10K)
Feb 01, 2013 06:31 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
NBY
Compare to S&P
YTD
32.74 %
21.73 %
4 Weeks
20.00 %
20.13 %
12 Weeks
26.05 %
21.81 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-0.01 %
EPS Growth in Last Year:
0.00 %
Sales Growth in Last Quarter:
-69.44 %
Sales Growth in Last Quarter:
-9.51 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##